drugset / Trial / NCT06843993
Single-Ascending Dose Study of MK-2060 in Healthy Chinese Male Adult Participants (MK-2060-009)
RandomizedSequentialDouble-blindBasic science
Summary
The goal of the study is to learn about the safety of MK-2060 and if people tolerate it. Researchers also want to learn what happens to MK-2060 in a person's body over time.
Timeline
- Start
- 2023-03-01
- Primary completion
- 2023-10-27
- Completion
- 2023-10-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MK-2060 | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.